Pmwp#128 - adverse event reporting in the integrating clinical trials and real world endpoints data (icaredata) initiative

Ended Definitive Contract Awarded Last action

Contract number
75F40120C00191
Awardee
Awarding agency
Obligated
$518,382

Award facts

Contract value 100% obligated
$518,381.51 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Chicago, IL 60606, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00002 -$112,629
Other Administrative Action P00001 $0
Original award $631,011

About this award

The Department of Health and Human Services Food and Drug Administration awarded a definitive, cost-no-fee contract to the Alliance Nctn Foundation, a non-profit organization, for the "Adverse Event Reporting in the Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Initiative" with a potential value of $518,381.51. The contract, which does not have a set-aside designation, is for work to be performed in Chicago, Illinois and has a completion date of December 31, 2023. The ICAREDATA initiative aims to integrate clinical trial data and real-world data to improve adverse event reporting.

Quick answers

Who was awarded contract 75F40120C00191?

75F40120C00191 was awarded to Alliance Nctn Foundation by Food and Drug Administration (Department of Health and Human Services) on September 27, 2020.

How much is contract 75F40120C00191 worth?

The government has obligated $518,382 on 75F40120C00191.

Was contract 75F40120C00191 competed?

The extent of competition for 75F40120C00191 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award